Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-11 10:35 am Purchase | 2025-06-30 | 13G | KVH Industries, Inc. KVHI | JEC II Associates, LLC | 1,400,000 7.180% | 325,000 (+30.23%) | Filing History |
| 2024-08-27 4:04 pm Purchase | 2024-08-02 | 13G | KVH Industries, Inc. KVHI | JEC II Associates, LLC | 1,075,000 5.500% | 1,075,000 (New Position) | Filing History |
| 2023-04-10 08:05 am Purchase | 2023-03-30 | 13G | Forte Biosciences, Inc. FBRX | JEC II Associates, LLC | 45,640 5.430% | 45,640 (New Position) | Filing History |
| 2022-09-22 4:15 pm Sale | 2022-09-21 | 13D | Catalyst Biosciences, Inc. CBIO | JEC II Associates, LLC | 0 0.000% | -6,351 (Position Closed) | Filing History |
| 2022-08-01 4:15 pm Unchanged | 2022-07-31 | 13D | Catalyst Biosciences, Inc. CBIO | JEC II Associates, LLC | 6,351 8.000% | 0 (Unchanged) | Filing History |
| 2022-07-01 4:15 pm Unchanged | 2022-06-29 | 13D | Catalyst Biosciences, Inc. CBIO | JEC II Associates, LLC | 6,351 8.000% | 0 (Unchanged) | Filing History |
| 2022-06-21 5:02 pm Purchase | 2022-06-13 | 13D | Catalyst Biosciences, Inc. CBIO | JEC II Associates, LLC | 6,351 8.000% | 6,351 (New Position) | Filing History |